India · Delayed Price · Currency is INR GPT Healthcare Statistics
Total Valuation
GPT Healthcare has a market cap or net worth of INR 11.74 billion. The enterprise value is 12.18 billion.
| Market Cap | 11.74B |
| Enterprise Value | 12.18B |
Important Dates
The last earnings date was Monday, May 18, 2026.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | Jul 30, 2026 |
Share Statistics
GPT Healthcare has 82.05 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 82.05M |
| Shares Outstanding | 82.05M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | -0.42% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 14.66% |
| Float | 26.93M |
Valuation Ratios
The trailing PE ratio is 27.79 and the forward PE ratio is 18.59.
| PE Ratio | 27.79 |
| Forward PE | 18.59 |
| PS Ratio | 2.49 |
| PB Ratio | 4.36 |
| P/TBV Ratio | 4.37 |
| P/FCF Ratio | 29.85 |
| P/OCF Ratio | 14.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.47, with an EV/FCF ratio of 30.96.
| EV / Earnings | 28.85 |
| EV / Sales | 2.58 |
| EV / EBITDA | 14.47 |
| EV / EBIT | 21.34 |
| EV / FCF | 30.96 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.12 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.08 |
| Debt / FCF | 2.32 |
| Interest Coverage | 6.93 |
Financial Efficiency
Return on equity (ROE) is 16.32% and return on invested capital (ROIC) is 13.95%.
| Return on Equity (ROE) | 16.32% |
| Return on Assets (ROA) | 8.41% |
| Return on Invested Capital (ROIC) | 13.95% |
| Return on Capital Employed (ROCE) | 14.82% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | 2.46M |
| Profits Per Employee | 219,441 |
| Employee Count | 1,924 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 17.55 |
Taxes
In the past 12 months, GPT Healthcare has paid 125.85 million in taxes.
| Income Tax | 125.85M |
| Effective Tax Rate | 22.96% |
Stock Price Statistics
The stock price has decreased by -6.57% in the last 52 weeks. The beta is 0.49, so GPT Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -6.57% |
| 50-Day Moving Average | 134.29 |
| 200-Day Moving Average | 140.00 |
| Relative Strength Index (RSI) | 57.70 |
| Average Volume (20 Days) | 116,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GPT Healthcare had revenue of INR 4.73 billion and earned 422.21 million in profits. Earnings per share was 5.15.
| Revenue | 4.73B |
| Gross Profit | 2.98B |
| Operating Income | 570.95M |
| Pretax Income | 548.06M |
| Net Income | 422.21M |
| EBITDA | 841.83M |
| EBIT | 570.95M |
| Earnings Per Share (EPS) | 5.15 |
Balance Sheet
The company has 474.18 million in cash and 911.80 million in debt, with a net cash position of -437.62 million or -5.33 per share.
| Cash & Cash Equivalents | 474.18M |
| Total Debt | 911.80M |
| Net Cash | -437.62M |
| Net Cash Per Share | -5.33 |
| Equity (Book Value) | 2.69B |
| Book Value Per Share | 32.92 |
| Working Capital | 97.85M |
Cash Flow
In the last 12 months, operating cash flow was 811.61 million and capital expenditures -418.19 million, giving a free cash flow of 393.42 million.
| Operating Cash Flow | 811.61M |
| Capital Expenditures | -418.19M |
| Depreciation & Amortization | 270.88M |
| Net Borrowing | -88.94M |
| Free Cash Flow | 393.42M |
| FCF Per Share | 4.79 |
Margins
Gross margin is 63.15%, with operating and profit margins of 12.08% and 8.93%.
| Gross Margin | 63.15% |
| Operating Margin | 12.08% |
| Pretax Margin | 11.60% |
| Profit Margin | 8.93% |
| EBITDA Margin | 17.81% |
| EBIT Margin | 12.08% |
| FCF Margin | 8.33% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.76%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 1.76% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 48.59% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 1.84% |
| Earnings Yield | 3.59% |
| FCF Yield | 3.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |